SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001885
Filing Date
2024-11-12
Accepted
2024-11-12 16:45:32
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ckpt-20240930x10q.htm   iXBRL 10-Q 1516922
2 EX-31.1 ckpt-20240930xex31d1.htm EX-31.1 10259
3 EX-31.2 ckpt-20240930xex31d2.htm EX-31.2 8889
4 EX-32.1 ckpt-20240930xex32d1.htm EX-32.1 5600
5 EX-32.2 ckpt-20240930xex32d2.htm EX-32.2 5536
  Complete submission text file 0001410578-24-001885.txt   6147487

Data Files

Seq Description Document Type Size
6 EX-101.SCH ckpt-20240930.xsd EX-101.SCH 43138
7 EX-101.CAL ckpt-20240930_cal.xml EX-101.CAL 23110
8 EX-101.DEF ckpt-20240930_def.xml EX-101.DEF 202126
9 EX-101.LAB ckpt-20240930_lab.xml EX-101.LAB 352377
10 EX-101.PRE ckpt-20240930_pre.xml EX-101.PRE 289381
59 EXTRACTED XBRL INSTANCE DOCUMENT ckpt-20240930x10q_htm.xml XML 827548
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 241449261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)